Support for this conclusion comes from the fact that decreasing insulin or IGF1 signaling has previously been shown to be beneficial in genetic mouse models of other neurodegenerative diseases including Alzheimer’s disease60 and Huntington’s disease.61 Here, IGF1 is linked to Huntington disease.